Collegium Pharmaceutical, Inc. COLL Operating Lease Right-of-Use Assets in Other Assets
Operating Lease Right-of-Use Assets in Other Assets at other companies
Segments
By geography
Other financials
Where this comes from
Reported directly by Collegium Pharmaceutical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Collegium Pharmaceutical, Inc.'s operating lease right-of-use assets in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Collegium Pharmaceutical, Inc.'s operating lease right-of-use assets in other assets?
- Collegium Pharmaceutical, Inc. (COLL) reported operating lease right-of-use assets in other assets of $3.98M in Q1 2026.
- How has Collegium Pharmaceutical, Inc.'s operating lease right-of-use assets in other assets changed year-over-year?
- Collegium Pharmaceutical, Inc.'s operating lease right-of-use assets in other assets decreased by 28.3% year-over-year, from $5.55M to $3.98M.
- What is the long-term trend for Collegium Pharmaceutical, Inc.'s operating lease right-of-use assets in other assets?
- Over 5 years (2020 to 2025), Collegium Pharmaceutical, Inc.'s operating lease right-of-use assets in other assets has grown at a -13.0% compound annual growth rate (CAGR), from $8.39M to $4.19M.